Predicting six-month mortality in adult hemophagocytic lymphohistiocytosis with machine learning: a prognostic approach utilizing laboratory data

利用机器学习预测成人噬血细胞性淋巴组织细胞增生症六个月死亡率:一种基于实验室数据的预后方法

阅读:2

Abstract

BACKGROUND: Hemophagocytic lymphohistiocytosis (HLH) is associated with high mortality rates. This study was conducted to develop and validate a predictive model for adult HLH patients at high risk of six months mortality using machine learning (ML) algorithms. METHODS: The study utilized univariate analysis and LASSO regression, incorporating eleven ML algorithms, to perform a comprehensive analysis of both admission and discharge variables. Model performance was assessed using metrics such as AUC, F1 score, Kaplan Meier (KM) curves, calibration curves and decision curve analysis (DCA). RESULTS: A total of 136 patients meeting the HLH-2004 criteria were included in this study. Among them, 59 patients received chemotherapy or other cytotoxic drugs, while the remaining 77 patients underwent symptomatic treatment. The median age was 52 years among nonsurvivors and 48 years among survivors, with 47 (42.6%) males in the nonsurvivor group and 31 (47.6%) in the survivor group. Age and nine discharge variables were identified as the most significant features for model construction. Random forest (RF) algorithm demonstrated superior predictive capabilities, achieving an AUC of 1.00, accuracy of 0.98 and F1 score of 0.98 in the training cohort, and an AUC of 0.89, accuracy of 0.85 and F1 score of 0.85 in the validation cohort. The top five predictors were all discharge variables (ferritin, white blood cell (WBC), albumin (ALB), platelet (PLT) and direct bilirubin (DB)). CONCLUSION: The predictive model developed in this study provides a valuable tool for clinicians to early identify high-risk HLH patients, thereby enabling more targeted and effective interventions.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。